Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Thyroid Cancer”

258 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 258 results

Testing effectiveness (Phase 2)Looking for participantsNCT07235566
What this trial is testing

MRG003 and Pucotenlimab to Treat Locally Advanced or Metastatic ATC/PDTC

Who this might be right for
Thyroid Cancer
Fudan University 60
Early research (Phase 1)Study completedNCT00004604
What this trial is testing

Biological Therapy in Treating Patients With Metastatic Cancer

Who this might be right for
Breast CancerColorectal CancerExtrahepatic Bile Duct Cancer+9 more
Duke University 24
Testing effectiveness (Phase 2)Temporarily pausedNCT05453799
What this trial is testing

Vudalimab for the Treatment of Locally Advanced or Metastatic Anaplastic Thyroid Cancer or Hurthle Cell Thyroid Cancer

Who this might be right for
Locally Advanced Thyroid Gland Anaplastic CarcinomaMetastatic Thyroid Gland Anaplastic CarcinomaMetastatic Thyroid Gland Oncocytic Carcinoma
Northwestern University 54
Early research (Phase 1)Study completedNCT00375245
What this trial is testing

Rapamycin With Grapefruit Juice for Advanced Malignancies

Who this might be right for
TumorsNeoplasm Metastasis
University of Chicago 41
Not applicableStudy completedNCT06051838
What this trial is testing

Prognostic Value of Tumor Deposits for Patients With Papillary Thyroid Carcinoma

Who this might be right for
Exploring the Prognostic Value of Tumor Deposits PTC Patients
Nanfang Hospital, Southern Medical University 541
Testing effectiveness (Phase 2)Study completedNCT00654238
What this trial is testing

Phase II Trial of Sorafenib (Nexavar) in Patients With Advanced Thyroid Cancer

Who this might be right for
Metastatic Differentiated Thyroid CancerMetastatic Poorly Differentiated Thyroid CancerMetastatic Anaplastic Thyroid Cancer+1 more
University of Pennsylvania 59
Testing effectiveness (Phase 2)Ended earlyNCT00923247
What this trial is testing

A Targeted Phase I/II Trial of ZD6474 (Vandetanib; ZACTIMA) Plus the Proteasome Inhibitor, Bortezomib (Velcade ), in Adults With Solid Tumors With a Focus on Hereditary or Sporadic, Locally Advanced or Metastatic Medullary Thyroid Cancer (MTC)

Who this might be right for
Medullary Thyroid Carcinoma
National Cancer Institute (NCI) 22
Testing effectiveness (Phase 2)Study completedNCT00390325
What this trial is testing

Sorafenib Tosylate in Treating Patients With Metastatic, Locally Advanced, or Recurrent Medullary Thyroid Cancer

Who this might be right for
Hereditary Thyroid Gland Medullary CarcinomaLocally Advanced Thyroid Gland Medullary CarcinomaMultiple Endocrine Neoplasia Type 2A+8 more
National Cancer Institute (NCI) 21
Not applicableApproved For MarketingNCT04204928
What this trial is testing

Pre-Approval Access Program (PAAP) for Pralsetinib (BLU-667) in Patients With Unresectable or Metastatic NSCLC or MTC

Who this might be right for
Non-Small Cell Lung CancerMedullary Thyroid Cancer
Blueprint Medicines Corporation
Testing effectiveness (Phase 2)Ended earlyNCT03787303
What this trial is testing

Study of Euthyroid Hypothyroxinemia in Metastatic Breast Carcinoma

Who this might be right for
Metastatic Breast CancerThyroid Dysfunction
Aultman Health Foundation 7
Early research (Phase 1)Study completedNCT00667641
What this trial is testing

Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors

Who this might be right for
Breast CancerColorectal CancerHead and Neck Cancer+6 more
University of Medicine and Dentistry of New Jersey 16
Testing effectiveness (Phase 2)Active Not RecruitingNCT05119296
What this trial is testing

Phase II Trial of Pembrolizumab in Metastatic or Locally Advanced Anaplastic/Undifferentiated Thyroid Cancer

Who this might be right for
Thyroid Cancer
Saad A Khan 9
Testing effectiveness (Phase 2)Study completedNCT03072160
What this trial is testing

Pembrolizumab in Recurrent or Metastatic Medullary Thyroid Cancer

Who this might be right for
Medullary Thyroid Cancer (MTC)
National Cancer Institute (NCI) 17
Testing effectiveness (Phase 2)Study completedNCT00176748
What this trial is testing

Treatment for Patients With Metastatic Thyroid Cancer

Who this might be right for
Thyroid Cancer
University of Michigan Rogel Cancer Center 3
Not applicableUnknownNCT00984191
What this trial is testing

Pilot 99mTechnetium-MIBI Single Photon Emission Computed Tomography - Computed Tomography (SPECT-CT) in Papillary Carcinoma (CA) Thyroid

Who this might be right for
Papillary Thyroid Cancer
Chulalongkorn University 15
Testing effectiveness (Phase 2)Study completedNCT00896454
What this trial is testing

Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium

Who this might be right for
Breast CancerHypercalcemia of MalignancyColon Cancer+13 more
Amgen 33
Not applicableStudy completedNCT01624220
What this trial is testing

A Prospective Study Using Implanted Fiducial Markers to Assess Treatment Accuracy and Esophageal Toxicity in Spinal Stereotactic Body Radiation Therapy

Who this might be right for
Spinal Tumor
M.D. Anderson Cancer Center 41
Testing effectiveness (Phase 2)Ended earlyNCT03002623
What this trial is testing

CUDC-907 Treatment in People With Metastatic and Locally Advanced Thyroid Cancer

Who this might be right for
Thyroid NeoplasmsPoorly Differentiated and Undifferentiated Thyroid CancerDifferentiated Thyroid Cancer
National Cancer Institute (NCI) 7
Testing effectiveness (Phase 2)Looking for participantsNCT03093116
What this trial is testing

Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

Who this might be right for
Locally Advanced Solid TumorsMetastatic Solid Tumors
Turning Point Therapeutics, Inc. 500
Testing effectiveness (Phase 2)Study completedNCT00094055
What this trial is testing

Study of the Anti-angiogenesis Agent AG-013736 in Patients With Metastatic Thyroid Cancer

Who this might be right for
Thyroid Neoplasms
Pfizer 60
Next Page